Moreover, the 36-month beta value for CELU is 0.77. Analysts have varying opinions on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for CELU is 13.81M and currently, short sellers hold a 10.69% of that float. On June 24, 2025, CELU’s average trading volume was 72.91K shares.
CELU) stock’s latest price update
The stock price of Celularity Inc (NASDAQ: CELU) has surged by 166355 when compared to previous closing price of 1.76, but the company has seen a 14.86% gain in its stock price over the last five trading sessions. globenewswire.com reported 2025-06-10 that Celularity retains financial and business advisor to provide outsourced accounting and consulting services during the transition period Celularity retains financial and business advisor to provide outsourced accounting and consulting services during the transition period
CELU’s Market Performance
Celularity Inc (CELU) has seen a 14.86% rise in stock performance for the week, with a -4.29% decline in the past month and a 10.44% surge in the past quarter. The volatility ratio for the week is 6.94%, and the volatility levels for the past 30 days are at 6.40% for CELU. The simple moving average for the last 20 days is -0.47% for CELU stock, with a simple moving average of -5.06% for the last 200 days.
Analysts’ Opinion of CELU
Many brokerage firms have already submitted their reports for CELU stocks, with Morgan Stanley repeating the rating for CELU by listing it as a “Underweight.” The predicted price for CELU in the upcoming period, according to Morgan Stanley is $1 based on the research report published on January 30, 2023 of the previous year 2023.
H.C. Wainwright gave a rating of “Buy” to CELU, setting the target price at $15 in the report published on June 22nd of the previous year.
CELU Trading at 8.55% from the 50-Day Moving Average
After a stumble in the market that brought CELU to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -61.49% of loss for the given period.
Stock Fundamentals for CELU
Current profitability levels for the company are sitting at:
- -0.71 for the present operating margin
- 0.84 for the gross margin
The net margin for Celularity Inc stands at -1.32. The total capital return value is set at -0.49. Equity return is now at value -232.51, with -25.28 for asset returns.
Based on Celularity Inc (CELU), the company’s capital structure generated 0.77 points at debt to capital in total, while cash flow to debt ratio is standing at -0.22. The debt to equity ratio resting at 3.29. The interest coverage ratio of the stock is 6.12.
Currently, EBITDA for the company is -43.71 million with net debt to EBITDA at -0.44. When we switch over and look at the enterprise to sales, we see a ratio of 1.41. The receivables turnover for the company is 4.0for trailing twelve months and the total asset turnover is 0.41. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.38.
Conclusion
To wrap up, the performance of Celularity Inc (CELU) has been mixed in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
